EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exposure‐Response Analysis for Time‐to‐Event Data in the Presence of Adaptive Dosing: Efficient Approaches and Pitfalls

Alexandra Lavalley-Morelle iD, Félicien Le Louedec, Richard Anziano, France Mentré iD, Martin Bergstrand iD

CPT: Pharmacometrics & Systems Pharmacology · 2026

DOI: 10.1002/psp4.70149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2026. Verfasst von Alexandra Lavalley-Morelle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmetheus A.B., Uppsala, Sweden. Hauptthemen laut MEDLINE: Models, Biological, Pharmacokinetics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Analyzing exposure‐response (E‐R) relationships for time‐to‐event (TTE) endpoints presents challenges due to the inherent time‐dependent nature of the data. Some authors address these difficulties by using a fixed timepoint approach, where exposure is assessed at a predetermined time rather than dynamically over time. (e.g., initial exposure or last exposure). The aim of the current work is to compare the use of time‐static and time‐varying metrics to assess the E‐R relationship through simulations. PK exposures were simulated from a one‐compartment model and TTE data from a parametric proportional hazard model, involving the weekly average PK concentration as a time‐varying covariate. Several scenarios were considered to handle the type of dosing (fixed or adaptive), the accumulation of the drug (low or strong), the type of event (efficacy, safety or independent), and the timing of the event onset (early or late). Wald tests on the exposure effect parameter were performed to assess the significance of the E‐R relationship. For each simulation scenario, the type‐I error and the power of the Wald tests were reported, revealing that no time‐static metric consistently produced reliable results across all conditions. In order to ensure adequate statistical properties, we recommend using time‐varying exposure, which shows good performance across all scenarios.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalPharmacokineticsHumansComputer SimulationDose-Response Relationship, DrugTime FactorsProportional Hazards Models

Stichwörter der Autor:innen

adaptive designdose reductionsdrug accumulationexposure‐responsetime‐static metricstime‐to‐event modelingtime‐varying exposure

Autor:innen und Institutionen

  • Pharmetheus A.B., Uppsala, Sweden.
  • Université Paris Cité, IAME, INSERM, Paris, France.
  • Département Epidémiologie Biostatistiques et Recherche Clinique, AP-HP, Hôpital Bichat, Paris, France.

ORCID-Profile: Alexandra Lavalley-Morelle, France Mentré, Martin Bergstrand

Zitieren

APA

Lavalley-Morelle, A., Le Louedec, F., Anziano, R., Mentré, F., & Bergstrand, M. (2026). Exposure‐Response Analysis for Time‐to‐Event Data in the Presence of Adaptive Dosing: Efficient Approaches and Pitfalls. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70149

Vancouver

Lavalley-Morelle A, Le Louedec F, Anziano R, Mentré F, Bergstrand M. Exposure‐Response Analysis for Time‐to‐Event Data in the Presence of Adaptive Dosing: Efficient Approaches and Pitfalls. CPT: Pharmacometrics & Systems Pharmacology. 2026. doi:10.1002/psp4.70149

BibTeX
@article{LavalleyMorelle2026,
  author = {Lavalley-Morelle, Alexandra and Le Louedec, Félicien and Anziano, Richard and Mentré, France and Bergstrand, Martin},
  title = {Exposure‐Response Analysis for Time‐to‐Event Data in the Presence of Adaptive Dosing: Efficient Approaches and Pitfalls},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2026},
  doi = {10.1002/psp4.70149}
}
Kostenlos starten →